Correlation Between Amicus Therapeutics and Cocrystal Pharma

Can any of the company-specific risk be diversified away by investing in both Amicus Therapeutics and Cocrystal Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Amicus Therapeutics and Cocrystal Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Amicus Therapeutics and Cocrystal Pharma, you can compare the effects of market volatilities on Amicus Therapeutics and Cocrystal Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Amicus Therapeutics with a short position of Cocrystal Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Amicus Therapeutics and Cocrystal Pharma.

Diversification Opportunities for Amicus Therapeutics and Cocrystal Pharma

0.47

Correlation Coefficient

Amicus Therapeutics  Cocrystal Pharma

Very weak diversification

The 3 months correlation between Amicus and Cocrystal is 0.47. Overlapping area represents the amount of risk that can be diversified away by holding Amicus Therapeutics and Cocrystal Pharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Cocrystal Pharma and Amicus Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Amicus Therapeutics are associated (or correlated) with Cocrystal Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Cocrystal Pharma has no effect on the direction of Amicus Therapeutics i.e., Amicus Therapeutics and Cocrystal Pharma go up and down completely randomly.

Pair Corralation between Amicus Therapeutics and Cocrystal Pharma

Given the investment horizon of 90 days Amicus Therapeutics is expected to generate 0.21 times more return on investment than Cocrystal Pharma. However, Amicus Therapeutics is 4.66 times less risky than Cocrystal Pharma. It trades about -0.07 of its potential returns per unit of risk. Cocrystal Pharma is currently generating about -0.07 per unit of risk. If you would invest  984.00  in Amicus Therapeutics on December 21, 2024 and sell it today you would lose (76.00) from holding Amicus Therapeutics or give up 7.72% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Weak
Accuracy	100.0%
Values	Daily Returns

Amicus Therapeutics  vs.  Cocrystal Pharma

Amicus Therapeutics

Risk-Adjusted Performance

Very Weak

Over the last 90 days Amicus Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest weak performance, the Stock's essential indicators remain sound and the latest tumult on Wall Street may also be a sign of longer-term gains for the firm shareholders.

Cocrystal Pharma

Risk-Adjusted Performance

Very Weak

Over the last 90 days Cocrystal Pharma has generated negative risk-adjusted returns adding no value to investors with long positions. Even with unfluctuating performance in the last few months, the Stock's fundamental indicators remain relatively invariable which may send shares a bit higher in April 2025. The latest agitation may also be a sign of long-running up-swing for the enterprise retail investors.

Pair Trading with Amicus Therapeutics and Cocrystal Pharma

The main advantage of trading using opposite Amicus Therapeutics and Cocrystal Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Amicus Therapeutics position performs unexpectedly, Cocrystal Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cocrystal Pharma will offset losses from the drop in Cocrystal Pharma's long position.

The idea behind Amicus Therapeutics and Cocrystal Pharma pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Aroon Oscillator module to analyze current equity momentum using Aroon Oscillator and other momentum ratios.